These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36203313)

  • 21. Bone age progression during the first year of growth hormone therapy in pre-pubertal children with idiopathic growth hormone deficiency, Turner syndrome or idiopathic short stature, and in short children born small for gestational age: analysis of data from KIGS (Pfizer International Growth Database).
    Darendeliler F; Ranke MB; Bakker B; Lindberg A; Cowell CT; Albertsson-Wikland K; Reiter EO; Price DA
    Horm Res; 2005; 63(1):40-7. PubMed ID: 15627781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hormone replacement therapy in children: The use of growth hormone and IGF-I.
    Pfäffle R
    Best Pract Res Clin Endocrinol Metab; 2015 Jun; 29(3):339-52. PubMed ID: 26051295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the efficacy and safety of recombinant human growth hormone in treating idiopathic short stature and growth hormone deficiency in children.
    Hou L; Liang Y; Wu W; Lin HH; Luo XP; Ying YQ
    Growth Horm IGF Res; 2020; 53-54():101331. PubMed ID: 32777706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cost-effectiveness of somatropin treatment for short children born small for gestational age (SGA) and children with growth hormone deficiency (GHD) in Sweden.
    Christensen T; Fidler C; Bentley A; Djurhuus C
    J Med Econ; 2010 Mar; 13(1):168-78. PubMed ID: 20136580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of growth hormone in children.
    Hindmarsh PC; Dattani MT
    Nat Clin Pract Endocrinol Metab; 2006 May; 2(5):260-8. PubMed ID: 16932297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of somatropin for the treatment of short children born small for gestational age.
    Christensen T; Buckland A; Bentley A; Djurhuus C; Baker-Searle R
    Clin Ther; 2010 Jun; 32(6):1068-82. PubMed ID: 20637961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic efficacy of recombinant human growth hormone in children with different etiologies of dwarfism from a pharmacoeconomic point of view.
    Ma Y; Sheng J; Wang L; Zhang Y; Liu L
    Medicine (Baltimore); 2024 Jun; 103(25):e38350. PubMed ID: 38905369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant growth hormone improves growth and adult height in patients with maternal inactivating GNAS mutations.
    Ertl DA; de Nanclares GP; Jüppner H; Hanna P; Pagnano A; Pereda A; Rothenbuhler A; Del Sindaco G; Ruiz-Cuevas P; Audrain C; Escribano A; Berkenou J; Gleiss A; Mantovani G; Linglart A
    Eur J Endocrinol; 2023 Jul; 189(1):123-131. PubMed ID: 37440712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GH treatment and its effect on bone mineral density, bone maturation and growth in short children born small for gestational age: 3-year results of a randomized, controlled GH trial.
    Arends NJ; Boonstra VH; Mulder PG; Odink RJ; Stokvis-Brantsma WH; Rongen-Westerlaken C; Mulder JC; Delemarre-Van de Waal H; Reeser HM; Jansen M; Waelkens JJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):779-87. PubMed ID: 14974922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two-Year Data from a Long-Term Phase IV Study of Recombinant Human Growth Hormone in Short Children Born Small for Gestational Age.
    Schwarz HP; Walczak M; Birkholz-Walerzak D; Szalecki M; Nanu M; Woehling H; Schuck E
    Adv Ther; 2016 Mar; 33(3):423-34. PubMed ID: 26886776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Responses to growth hormone (GH) therapy in short children with normal GH secretion and no bone age delay: an analysis of potential factors affecting their response to rhGH therapy. A controlled study.
    Soliman AT; Elawwa A; Itani M; Jour C; De Sanctis V
    Acta Biomed; 2019 Sep; 90(8-S):43-51. PubMed ID: 31544806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis and growth hormone (GH) therapy in children with GH deficiency: experience in King Chulalongkorn Memorial Hospital, Thailand.
    Wacharasindhu S; Supornsilchai V; Aroonparkmongkol S; Srivuthana S
    J Med Assoc Thai; 2007 Oct; 90(10):2047-52. PubMed ID: 18041422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation of Clinical Features and Growth Hormone Deficiency in Short Children Born Small For Gestational Age].
    Ikegami T; Araki S; Kuwamura M; Taku A; Saito R; Goto M; Kubo K; Kawagoe R; Yamamoto Y; Kawada Y; Kusuhara K
    J UOEH; 2018; 40(3):253-257. PubMed ID: 30224622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Real-life GH dosing patterns in children with GHD, TS or born SGA: a report from the NordiNet® International Outcome Study.
    Blankenstein O; Snajderova M; Blair J; Pournara E; Pedersen BT; Petit IO
    Eur J Endocrinol; 2017 Aug; 177(2):145-155. PubMed ID: 28522645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term safety and effectiveness of growth hormone therapy in Korean children with growth disorders: 5-year results of LG Growth Study.
    Rhie YJ; Yoo JH; Choi JH; Chae HW; Kim JH; Chung S; Hwang IT; Shin CH; Kim EY; Kim HS
    PLoS One; 2019; 14(5):e0216927. PubMed ID: 31095622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Auxological and metabolic effects of long-term treatment with recombinant growth hormone in children born small for gestational age: a retrospective study.
    Ferrigno R; Savanelli MC; Cioffi D; Pellino V; Klain A
    Endocrine; 2024 Apr; 84(1):213-222. PubMed ID: 38214878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The growth hormone cascade: progress and long-term results of growth hormone treatment in growth hormone deficiency.
    Grumbach MM; Bin-Abbas BS; Kaplan SL
    Horm Res; 1998; 49 Suppl 2():41-57. PubMed ID: 9730672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF GROWTH HORMONE DEFICIENCY IN ADULTS AND PATIENTS TRANSITIONING FROM PEDIATRIC TO ADULT CARE.
    Yuen KCJ; Biller BMK; Radovick S; Carmichael JD; Jasim S; Pantalone KM; Hoffman AR
    Endocr Pract; 2019 Nov; 25(11):1191-1232. PubMed ID: 31760824
    [No Abstract]   [Full Text] [Related]  

  • 39. Practical tools to identify short children born small-for-gestational-age eligible for rhGH treatment according to Italian regulation.
    Tornese G; Pricci F; Pellegrin MC; Villa M; Rotondi D; Agazio E; Barbi E
    Ital J Pediatr; 2019 Oct; 45(1):130. PubMed ID: 31639023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth response to growth hormone (GH) treatment in children with GH deficiency (GHD) and those with idiopathic short stature (ISS) based on their pretreatment insulin-like growth factor 1 (IGFI) levels and at diagnosis and IGFI increment on treatment.
    Soliman A; Rogol AD; Elsiddig S; Khalil A; Alaaraj N; Alyafie F; Ahmed H; Elawwa A
    J Pediatr Endocrinol Metab; 2021 Oct; 34(10):1263-1271. PubMed ID: 34291621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.